Medical device maker AngioDynamics Inc. has experienced another recall setback, halting sales of its tumor-zapping NanoKnife device due to a software issue. The company announced the recall this week and again revised its 2012 fiscal guidance downward. A software update on the device was recently flagged by the Food and Drug Administration. The FDA said the update didn’t follow the proper channel for approval, and further oversight was needed. AngioDynamics has decided to remove the feature and resume shipments without it. Customers who received the software have been contacted about the change. Shipments should start sometime before the firm’s fiscal year ends, on May 31.
